Rob,

Clinical trial is in Phase II (efficacy). Phase I was toxicity. It would go to Phase III (comparing with other protocols) if Phase II proves effective. Trial is UAB only with 35 patients. They currently have 14. They do not know if protocol is more effective than conventional...they just said early results are promising. IMRT would not be used in clinical study which is why I had to get them to go back and see if I am IMRT candidate. Study is only six months old.

UAB is a comprehensive cancer center with tumor board etc.

I asked them to have someone in treatment call me but that has not yet happened.

Bill